BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying the major medtech wielded its sector dominance to push competing products out o | The rival ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for ...

Reuters reported the suit, which was filed in the court for the Eastern District of Pennsylvania on Dec. 19. According to the ...

IGIB, has launched India's first Centre of Excellence for Single-Cell Multiomics to enhance research in immunity, cancer, and ...

BD, a leading global medical technology company, and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector, announced a definitive agreement for BD to ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters. As part of a $10 million investment in 2024, new ...

As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...

BD announced Aug. 25 the promotion of two executives to segment presidents. They will also serve on the Franklin Lakes-based medical tech provider’s executive leadership team. Michael “Mike” Garrison ...

BD (Becton, Dickinson and Company), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout ...

Investors in Becton, Dickinson and Company BDX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $225.00 Put had some of the ...